Many private investors have graciously given positive reviews for StocksHaven Investments’ latest conference call with Hemispherx BioPharma (Public, AMEX:HEB). Due to this, a follow up list providing essentials and guidance for successful conference calls seemed like a great idea. So without further adue, here is Michael Vlaicu’s strategies on championing this task:
1. INTRODUCTION Many [...]

Hemispherx BioPharma Inc.
(Public, AMEX:HEB)
At approximately 4:30pm EST, 5/15/09, StocksHaven Investments began the call conference scheduled with Chairman & CEO of Hemispherx BioPharma Inc., Dr. William Carter. The interview process was a tremendous success and was concluded as of 5:00pm EST, 5/15/09. Many issues and concerns of private individual investors were raised and answered in a [...]